| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Dec 18, 2025 | Arcus Biosciences, Inc. | General Counsel | Sell | 40.0 | -14,468 | -10.39% | ✗ | $318.5K |
| Dec 15, 2024 | Dec 17, 2024 | Arcus Biosciences, Inc. | General Counsel | Sell | 42.5 | -11,339 | -10.13% | ✗ | $182.3K |
| Jun 15, 2024 | Jun 18, 2024 | Arcus Biosciences, Inc. | General Counsel | Sell | 42.5 | -4,182 | -3.62% | ✗ | $71K |
| Dec 18, 2023 | Dec 20, 2023 | Arcus Biosciences, Inc. | General Counsel | Sell | 42.5 | -8,067 | -8.41% | ✗ | $144.5K |
| Jun 16, 2023 | Jun 16, 2023 | Arcus Biosciences, Inc. | General Counsel | Sell | 42.5 | -2,892 | -2.93% | ✗ | $56K |
| Dec 16, 2022 | Dec 16, 2022 | Arcus Biosciences, Inc. | General Counsel | Sell | 42.5 | -2,523 | -8.11% | ✗ | $77.6K |
| Jun 16, 2022 | Jun 21, 2022 | Arcus Biosciences, Inc. | General Counsel | Sell | 42.5 | -2,922 | -10.89% | ✗ | $62.7K |
| Dec 16, 2021 | Dec 20, 2021 | Arcus Biosciences, Inc. | General Counsel | Sell | 46.3 | -1,109 | -5.94% | ✗ | $44.5K |
| Jun 16, 2021 | Jun 21, 2021 | Arcus Biosciences, Inc. | General Counsel | Sell | 42.5 | -2,915 | -15.95% | ✗ | $69.6K |